DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Perflutren Protein-Type a Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients with Liver Cancer

Phase 2

Active, not recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: Yttrium-90 Microsphere Radioembolization
Drug: Perflutren Protein-Type A Microspheres
Procedure: Dynamic Contrast-Enhanced Ultrasound Imaging

First Posted Date: 2017-06-26

Last Posted Date: 2025-02-12

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 104

Registration Number: NCT03199274

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine

Early Phase 1

Withdrawn

Conditions: Coronary Artery Disease

Interventions: Drug: Sterile Saline
Drug: Nicardipine

First Posted Date: 2017-06-12

Last Posted Date: 2024-04-26

Lead Sponsor: Thomas Jefferson University

Registration Number: NCT03184155

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets

Not Applicable

Completed

Conditions: Healthy
Prehypertension

Interventions: Dietary Supplement: melatonin

First Posted Date: 2017-06-06

Last Posted Date: 2017-06-08

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 31

Registration Number: NCT03178396

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Opioid Consumption After Orthopaedic Surgery

Not Applicable

Conditions: Orthopedic Disorder

Interventions: Behavioral: Pre-operative opioid counseling

First Posted Date: 2017-06-01

Last Posted Date: 2017-06-01

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 280

Registration Number: NCT03173131

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks

Phase 4

Withdrawn

Conditions: Migraine

Interventions: Combination Product: lidocaine/bupivacaine
Drug: Saline

First Posted Date: 2017-05-18

Last Posted Date: 2021-11-26

Lead Sponsor: Thomas Jefferson University

Registration Number: NCT03159000

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

Phase 2

Suspended

Conditions: Thyroid Cancer

Interventions: Drug: Lenvatinib
Drug: Everolimus

First Posted Date: 2017-05-04

Last Posted Date: 2021-10-15

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 5

Registration Number: NCT03139747

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus

Phase 1

Completed

Conditions: Healthy
Pharmacokinetics
Venous Thromboembolism

Interventions: Drug: Apixaban alone
Drug: Tacrolimus
Drug: Cyclosporine
Drug: Apixaban

First Posted Date: 2017-03-20

Last Posted Date: 2017-10-11

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 12

Registration Number: NCT03083782

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

One Step Versus Two Step Approach for Gestational Diabetes Mellitus Screening

Not Applicable

Conditions: Gestational Diabetes

Interventions: Diagnostic Test: GDM screening with 75 g 2 hour GTT
Diagnostic Test: GDM screening with two step approach

First Posted Date: 2017-03-08

Last Posted Date: 2017-03-08

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 284

Registration Number: NCT03073330

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Early Phase 1

Conditions: Diverticulitis
Colorectal Neoplasms
Inflammatory Bowel Diseases
Surgical Site Infection

Interventions: Drug: Polyethylene Glycol
Drug: Metronidazole Hydrochloride
Drug: Neomycin
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2017-02-03

Last Posted Date: 2018-08-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 224

Registration Number: NCT03042091

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors

Terminated

Conditions: Carotid Artery Disease

First Posted Date: 2017-02-02

Last Posted Date: 2021-11-11

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 414

Registration Number: NCT03041168

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy